The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final overall survival analysis of EXAM, an international, double-blind, randomized, placebo-controlled phase III trial of cabozantinib (Cabo) in medullary thyroid carcinoma (MTC) patients with documented RECIST progression at baseline.
 
Martin Schlumberger
Honoraria - AstraZeneca; Bayer; Eisai; Exelixis
Research Funding - AstraZeneca; Bayer; Eisai; Exelixis
 
Rossella Elisei
Honoraria - Bayer; Exelixis; Genzyme
Consulting or Advisory Role - Novartis
Speakers' Bureau - Bayer; Exelixis; Genzyme
Travel, Accommodations, Expenses - Genzyme
 
Stefan Müller
Consulting or Advisory Role - BTG; SOBI
Research Funding - BTG
Travel, Accommodations, Expenses - BTG
 
Patrick Schöffski
Honoraria - AstraZeneca; Exelixis; SOBI
Research Funding - Exelixis
 
Marcia S. Brose
Honoraria - Bayer; Exelixis; Onyx
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Exelixis; Onyx; Oxigene
Research Funding - Bayer (Inst); Eisai (Inst); Exelixis (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bayer; Eisai; Onyx
 
Manisha H. Shah
Consulting or Advisory Role - Eisai
Research Funding - Eisai; Exelixis
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Debiopharm Group; Eisai; GlaxoSmithKline; Merck Serono; MSD; Novartis; SOBI; VentiRx
Research Funding - Amgen; AstraZeneca; Boehringer Ingelheim; Eisai; Exelixis; Merck Serono; MSD; Novartis; Roche Pharma AG
Travel, Accommodations, Expenses - Bayer; Celgene; Debiopharm Group; Merck Serono; MSD; SOBI
 
Barbara Jarzab
Honoraria - AstraZeneca; Bayer; Eisai; Exelixis; Ipsen; Novartis; SOBI
Consulting or Advisory Role - AstraZeneca; SOBI
Speakers' Bureau - Ipsen; Novartis
Expert Testimony - AstraZeneca; Bayer
Travel, Accommodations, Expenses - Genzyme; Ipsen; Novartis; SOBI
 
Viktor Medvedev
No Relationships to Disclose
 
Michael Kreissl
Honoraria - AstraZeneca; Bayer; SOBI
Consulting or Advisory Role - AstraZeneca; Bayer; SOBI
Travel, Accommodations, Expenses - AstraZeneca; Sanofi
 
Ezra E. W. Cohen
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Merck; Novartis; VentiRx
Speakers' Bureau - Bayer; Biodesix
 
Lori J. Wirth
Honoraria - AstraZeneca; Eisai
 
Haythem Y. Ali
No Relationships to Disclose
 
Colin Hessel
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Yifah Yaron
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Douglas Wilmot Ball
Consulting or Advisory Role - Eisai
Research Funding - Eisai; Exelixis
 
Barry Nelkin
No Relationships to Disclose
 
Steven I. Sherman
Honoraria - Eisai; Genzyme; Onyx
Consulting or Advisory Role - Bayer; Eisai; Exelixis; Lilly; Novo Nordisk; Veracyte
Research Funding - Bayer; Eisai; Exelixis